Clinical Trial

Pseudoexfoliation and Carpal Tunnel Study

Completed
View on ClinicalTrials.gov →
Summary
This prospective, single-center case-control study aimed to investigate the association between pseudoexfoliation syndrome (PES) and carpal tunnel syndrome (CTS) using biochemical markers. A total of 159 participants aged 50-80 years were categorized into PES, CTS, and control groups. Diagnoses were confirmed by slit-lamp biomicroscopy for PES and electrophysiological evaluation (EMG) for CTS. Serum biomarkers, including homocysteine, methylmalonic acid, paraoxonase-1 (PON1), homocysteine thiolactonase (HTLase), and matrix metalloproteinases (MMP-2 and MMP-9), were measured. Group comparisons, diagnostic performance (ROC analysis), and independent associations (multinomial logistic regression) were evaluated. Comorbidities were recorded and analyzed in subgroup analyses.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-04-19; most recent amendment 2026-04-15.
Status change: Enrolling by Invitation → Completed 2026-01-31
Trial Details
NCT Number NCT06946030
Lead Sponsor Ankara Training and Research Hospital
Conditions Pseudoexfoliation Syndrome, Carpal Tunnel Syndrome (CTS)
Enrollment 159 participants
Start Date 2025-05-01
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-17